Litcius/Paper detail

Topical Janus kinase-signal transducers and activators of transcription inhibitor tofacitinib is effective in reducing nonatopic dermatitis chronic itch: A case series

Teresa Ju, Angelina Labib, Ashley Vander Does, Gil Yosipovitch

2022Journal of the American Academy of Dermatology23 citationsDOIOpen Access PDF

Topics & Concepts

TofacitinibMedicineAtopic dermatitisJanus kinase inhibitorDermatologyJanus kinaseRefractory (planetary science)Randomized controlled trialClinical trialRheumatoid arthritisInternal medicinePharmacologyCytokinePhysicsAstrobiologyDermatology and Skin DiseasesAllergic Rhinitis and SensitizationUrticaria and Related Conditions
Topical Janus kinase-signal transducers and activators of transcription inhibitor tofacitinib is effective in reducing nonatopic dermatitis chronic itch: A case series | Litcius